3 658 new cases recorded as SA opens NantSA vaccine production campus.
By Lehlohonolo Lehana.
The National Institute for Communicable Diseases (NICD), reports 3 658 new COVID-19 cases that have been identified in South Africa, which brings the total number of laboratory-confirmed cases to 3 564 578.
The majority of new cases today are from Gauteng Province and KwaZulu-Natal (22% each), followed by Western Cape (20%). Eastern Cape accounted for 9%; Limpopo accounted for 8%; North West accounted for 6%; Free State and Mpumalanga each accounted for 5% respectively; and Northern Cape accounted for 2% of today’s new cases.
This increase represents a 9.2% positivity rate.
The proportion of positive new cases/total new tested today is 9.2% which is lower than yesterday (9.3%). The 7-day average is 12.1% today, which is lower than yesterday (12.8%). The 7-day moving average daily number of cases has decreased.
Due to the ongoing audit exercise by the National Department of Health (NDoH), there may be a backlog of COVID-19 mortality cases reported. Today, the NDoH reports 100 deaths and of these, 30 occurred in the past 24 – 48 hours. This brings the total fatalities to 93 551 to date.
Meanwhile President Cyril Ramaphosa is expected to join Dr Patrick Soon-Shiong, founder of the multinational conglomerate NantWorks, LLC, in launching the NantSA vaccine manufacturing campus in Brackenfell, Cape Town, on Wednesday.
The President and Dr Soon-Shiong will also launch the Coalition to Accelerate Africa’s Access to Advanced Healthcare (The AAAH Coalition).
This launch comes after an announcement made by Dr Soon-Shiong in September last year of an ambitious initiative to build capacity for advanced health care in Africa.
NantSA, a division of NantWorks, and The AAAH Coalition aim to accelerate domestic production of pharmaceuticals, biologics and vaccines that will reach patients across the African continent.
In a statement on Monday, The Presidency said that through the synergistic efforts of members of The AAAH Coalition, self-reliance will be accelerated around next-generation vaccines manufactured in South Africa for Africa, innovative therapeutics and pandemic preparedness.
"With the support of the Chan Soon-Shiong Family Foundation, institutes for infectious disease and cancer centres of excellence will be established at the universities of Cape Town and the Witwatersrand and the Chan Soon-Shiong Centre for Epidemic Response and Innovation (CSS CERI) at the University of Stellenbosch,"the Presidency said.
Ramaphosa and Dr Soon-Shiong will perform a ribbon-cutting for the official launch of the NantSA vaccine manufacturing campus at Brackengate and also present the vision and mission of The AAAH Coalitions.
The event will be attended by a select group of invitees including representatives of government, academia and the biotech industry.